BofA Securities Maintains Cellebrite(CLBT.US) With Buy Rating
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024
Cellebrite DI Ltd. (CLBT) Hit a 52 Week High, Can the Run Continue?
Automotive Remote Diagnostics Global Strategic Business Report 2024-2030 Featuring AsTech, Aurora Labs, Cellebrite, Commwell, DFx, Dsruptive Subdermals, Higo Sense, Infisense, KORE, & Kyoto Promed
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $23
Cellebrite DI (CLBT) Gets a Buy From Craig-Hallum
Cellebrite Patents Its Remote Mobile Collection Capabilities for Businesses
Cellebrite DI Is Maintained at Buy by TD Cowen
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $23
TD Cowen analyst Shaul Eyal maintains $Cellebrite(CLBT.US)$ with a buy rating, and adjusts the target price from $15 to $23.According to TipRanks data, the analyst has a success rate of 69.6% and a
Express News | Cellebrite DI Ltd : TD Cowen Raises Target Price to $23 From $20
Cellebrite DI Shareholders Approve All Proposals
Analysts Offer Insights on Technology Companies: Cellebrite DI (CLBT), Stratasys (SSYS) and Mitek Systems (MITK)
Cellebrite Enhances Investigative Analytics Solution With Amazon Web Services (AWS)
Cellebrite Shares Surge, Triggering Stock Issuance
It May Be Possible That Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Compensation Could Get Bumped Up
Cellebrite DI Warrant Exercise Deadline Approaches
Cellebrite DI Announces Warrant Redemption Plan
Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)